Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis

Journal of Toxicological Sciences

Volumn 41, Issue 4, 2016, Pages 561-572

  Dong, Shu ^a   Chen, Qi Long ^a   Song, Ya Nan ^a   Sun, Yang ^a   Wei, Bin ^a   Li, Xiao Yan ^a   Hu, Yi Yang ^b   Liu, Ping ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CCl4; Integrative analysis; Liver fibrosis; Proteomics; Toxicity; Transcriptomics

Indexed keywords

CARBON TETRACHLORIDE; HYDROXYPROLINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; DETOXIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; LETTER; LIVER CELL CARCINOMA; LIVER INJURY; NONHUMAN; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; BIOLOGY; CHEMICALLY INDUCED; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PROCEDURES; PROTEOMICS; REPRODUCIBILITY; TOXIC HEPATITIS; WISTAR RAT;

ANIMALS; CARBON TETRACHLORIDE; CHEMICAL AND DRUG INDUCED LIVER INJURY; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; LIVER; LIVER CIRRHOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; PROTEOMICS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

EID: 84979294082     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.41.561     Document Type: Letter

References (39)

1. Attia, Y.M., Elalkamy, E.F., Hammam, O.A., Mahmoud, S.S. and El-hatib, A.S. (2013): Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection. Parasit. Vectors, 6, 199.
2. Bahr, M.J., Ockenga, J., Böker, K.H., Manns, M.P. and Tietge, U.J. (2006): Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am. J. Physiol. Endocrinol. Metab., 291, E199-206.
3. Bechmann, L.P., Hannivoort, R.A., Gerken, G., Hotamisligil, G.S., Trauner, M. and Canbay, A. (2012): The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol., 56, 952-964.
4. Bian, D., Zhang, J., Wu, X., Dou, Y., Yang, Y., Tan, Q., Xia, Y., Gong, Z. and Dai, Y. (2013): Asiatic Acid Isolated From Centella Asiatica Inhibits TGF-β1-induced Collagen Expression in Human Keloid Fibroblasts via PPAR-γ Activation. Int. J. Biol. Sci., 9, 1032-1042.
5. Bou Khalil, M., Blais, A., Figeys, D. and Yao, Z. (2010): Lipin - The bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta, 1801, 1249-1259.
6. Chang, W.T., Ker, C.G., Hung, H.C., Lee, K.T., Chen, L.S., Chiang, H.C. and Huang, M.C. (2008): Albumin and prealbumin may predict retinol status in patients with liver cirrhosis. Hepatogastroenterology, 55, 1681-1685.
7. de Paula, T.P., Ramalho, A. and Braulio, V.B. (2010): The effectiveness of relative dose response to retinol intake as an evaluation of vitamin A status of cirrhotic patients. J. Hum. Nutr. Diet., 23, 583-589.
8. Dong, S., Chen, Q.L., Feng, Q., Hu, Y.Y., Liu, P. and Su, S.B. (2015): Study on molecular mechanism of improving rat liver fibrosis with Fuzheng Huayu Formula based on gene profile. CJTCMP, 30, 1812-1817.
9. Duval, F., Moreno-Cuevas, J.E., González-Garza, M.T., Maldonado-Bernal, C. and Cruz-Vega, D.E. (2015): Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. Int. J. Inflam., 2015, 943497.
10. Duval, F., Moreno-Cuevas, J.E., González-Garza, M.T., Rodríguez-Montalvo, C. and Cruz-Vega, D.E. (2014): Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin. Med., 9, 27.
11. Dwyer, J.R., Donkor, J., Zhang, P., Csaki, L.S., Vergnes, L., Lee, J.M., Dewald, J., Brindley, D.N., Atti, E., Tetradis, S., Yoshinaga, Y., De Jong, P.J., Fong, L.G., Young, S.G. and Reue, K. (2012): Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis in liver and aging cerebellum. Proc. Natl. Acad. Sci. USA, 109, E2486- E2495.
12. 4- induced hepatocellular toxicity. J. Am. Coll. Nutr., 34, 228-231.
13. El-Bini, Dhouib.I., Lasram, M.M., Annabi, A., Gharbi, N. and El-Fazaa, S. (2015): A comparative study on toxicity induced by carbosulfan and malathion in Wistar rat liver and spleen. Pestic. Biochem. Physiol., 124, 21-28.
14. Enomoto, M., Morikawa, H., Tamori, A. and Kawada, N. (2014): Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J. Gastroenterol., 20, 12031-12038.
15. Guo, C., Xu, L., He, Q., Liang, T., Duan, X. and Li, R. (2013): Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway. Food Chem. Toxicol., 56, 436-442.
16. Hammond, L.E., Gallagher, P.A., Wang, S., Hiller, S., Kluckman, K.D., Posey-Marcos, E.L., Maeda, N. and Coleman, R.A. (2002): Mitochondrial glycerol-3-phosphate acyltransferase- deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol. Cell Biol., 22, 8204-8214.
17. Heeba, G.H. and Mahmoud, M.E. (2014): Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B. Environ Toxicol. Pharmacol., 37, 662-671.
18. Heeba, G.H. and Morsy, M.A. (2015): Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Environ. Toxicol. Pharmacol., 40, 907-914.
19. Holownia, A, Mroz, R.M., Wielgat, P., Jakubow, P., Jablonski, J., Sulek, J. and Braszko, J.J. (2014): Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. Naunyn Schmiedebergs Arch. Pharmacol., 387, 271- 280.
20. Huang, Z.G., Zhai, W.R., Zhang, Y.E. and Zhang, X.R. (1998): Study of heteroserum-induced rat liver fibrosis model and its mechanism. World J. Gastroenterol., 4, 206-209.
21. Karsdal, M.A., Manon-Jensen, T., Genovese, F., Kristensen, J.H., Nielsen, M.J., Sand, J.M., Hansen, N.U., Bay-Jensen, A.C., Bager, C.L., Krag, A., Blanchard, A., Krarup, H., Leeming, D.J. and Schuppan, D. (2015): Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. Am. J. Physiol. Gastrointest Liver Physiol., 308, G807-830.
22. Kong, X., Zhou, W., Wan, J.B., Zhang, Q., Ni, J. and Hu, Y. (2015): An Integrative Thrombosis Network: Visualization and Topological Analysis. Evid. Based Complement. Alternat. Med., 2015, 265303.
23. Kumar, V., Mundra, V. and Mahato, R.I. (2014): Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis. Pharm. Res., 31, 1158-1169.
24. Le, H.D., Meisel, J.A., de Meijer, V.E., Fallon, E.M., Gura, K.M., Nose, V., Bistrian, B.R. and Puder, M. (2012): Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J. Parenter. Enteral. Nutr., 36, 431- 441.
25. Lee, H., Jeong, H., Park, S., Yoo, W., Choi, S., Choi, K., Lee, M.G., Lee, M., Cha, D., Kim, Y.S., Han, J., Kim, W., Park, S.H. and Oh, J. (2015): Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis. EMBO Mol. Med., 7, 819- 830.
26. Li, S., Tan, H.Y., Wang, N., Zhang, Z.J., Lao, L., Wong, C.W. and Feng, Y. (2015): The role of oxidative stress and antioxidants in liver diseases. Int. J. Mol. Sci., 16, 26087-26124.
27. Li, Z.M., Sun, J.H. and Yang, X.M. (2015): Recent advances in molecular magnetic resonance imaging of liver fibrosis. Biomed. Res. Int., 2015, 595467.
28. Meierhofer, D., Weidner, C. and Sauer, S. (2014): Integrative analysis of transcriptomics, proteomics, and metabolomics data of white adipose and liver tissue of high-fat diet and rosiglitazonetreated insulin-resistant mice identified pathway alterations and molecular hubs. J. Proteome Res., 13, 5592-5602.
29. Miyazaki, H., Takitani, K., Koh, M., Inoue, A., Kishi, K. and Tamai, H. (2014): Retinol statue and expression of retinol-related proteins in methionine-choline deficient rats. J. Nutr. Sci. Vitaminol., 60, 78-85.
30. Nishikawa, T., Bellance, N., Damm, A., Bing, H., Zhu, Z., Handa, K., Yovchev, M.I., Sehgal, V., Moss, T.J., Oertel, M., Ram, P.T., Pipinos, I.I., Soto-Gutierrez, A., Fox, I.J. and Nagrath, D. (2014): A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J. Hepatol., 60, 1203-1211.
31. Osada, J. (2013): The use of transcriptomics to unveil the role of nutrients in mammalian liver. ISRN Nutr., 2013, 403792.
32. Park, S., Choi, S., Lee, M.G., Lim, C. and Oh, J. (2012): Retinol binding protein-albumin domain III fusion protein deactivates hepatic stellate cells. Mol Cells., 34, 517-522.
33. Prentki, M. and Madiraju, S.R. (2008): Glycerolipid metabolism and signaling in health and disease. Endocr Rev., 29, 647-676.
34. Roy, S., Benz, F., Vargas Cardenas, D., Vucur, M., Gautheron, J., Schneider, A., Hellerbrand, C., Pottier, N., Alder, J., Tacke, F., Trautwein, C., Roderburg, C. and Luedde, T. (2015): miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis. J. Dig. Dis., 16, 513-524.
35. 4 induced toxicity in rats. BMC Res Notes., 7, 224.
36. 4-induced hepatotoxicity in rats. Drug Chem. Toxicol., 36, 42-47.
37. Xie, C., Li, X., Wu, J., Liang, Z., Deng, F., Xie, W., Zhu, M., Zhu, J., Zhu, W., Geng, S. and Zhong, C. (2015): Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2/arachidonic acid pathway. Inflammation, 38, 1639-1648.
38. Xuan, J., Chen, S., Ning, B., Tolleson, W.H. and Guo, L. (2015): Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. Chem Biol Interact., pii: S0009-2797(15)30088-0.
39. Yin, C., Evason, K.J., Asahina, K. and Stainier, D.Y. (2013): Hepatic stellate cells in liver development, regeneration, and cancer. J. Clin. Invest., 123, 1902-1910.